CARMEN CUMPSTON: Open Payments
NPI 1588106488 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 21 payments from 7 companies in 2025. Trend: 2023 $369 · 2024 $237 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $174 |
| Lundbeck LLC | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: VRAYLAR, UBRELVY, VYEPTI, AUSTEDO XR, Auvelity, MOUNJARO, QULIPTA, Ozempic.
Industry payments across OK — which companies pay providers there.
